✦ LIBER ✦

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18 to 34-week, open-label, extension period

✍ Scribed by P. Moulin; M. André; H. Alawi; L.C. Dos Santos; A.K. Khalid; D. Koev; R. Moore; V. Serban; B. Picandet; M. Francillard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of atorvastatin in h

✍ Carlos A. Aguilar-Salinas; Francisco J. Gómez-Pérez; Carlos Posadas-Romero; Cuau 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Efficacy and safety of alogliptin added

✍ Seino, Yutaka; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 270 KB

Durability of efficacy and long-term saf

✍ Alan J. Garber; Simon Bruce; Fred T. Fiedorek 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 869 KB

Durable efficacy of metformin/glibenclam

✍ L. Blonde; S. Joyal; D. Henry; H. Howlett 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Once-Weekly Exenatide Versus Once- or Tw

✍ Davies, M.; Heller, S.; Sreenan, S.; Sapin, H.; Adetunji, O.; Tahbaz, A.; Vora, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 223 KB

Linagliptin monotherapy in type 2 diabet

✍ Barnett, A. H.; Patel, S.; Harper, R.; Toorawa, R.; Thiemann, S.; von Eynatten, 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB